This report summarizes information on percutaneous transluminal coronary angioplasty (PTCA) contained in research published between 1982 and October 1990. In particular, it deals with research on the efficacy, complications, costs, utilization, and indications for PTCA. The report includes a comprehensive set of indications for performing this procedure, and ratings of the appropriateness and necessity for each indication.
This report is part of the RAND Corporation Joint report health series. The joint report was a product of the RAND Corporation from 1988 to 1993 that included documents published jointly with other organizations, which transmitted major research findings and final research.
Permission is given to duplicate this electronic document for personal use only, as long as it is unaltered and complete. Copies may not be duplicated for commercial purposes. Unauthorized posting of RAND PDFs to a non-RAND Web site is prohibited. RAND PDFs are protected under copyright law. For information on reprint and linking permissions, please visit the RAND Permissions page.
The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.